Clinical Trial Update: Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Gliadel wafers with radiation therapy and temozolomide, with bevacizumab, for newly diagnosed glioblastoma multiforme; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Avastin (bevacizumab)
• GLIADEL (Carmustine)
• Temodar (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Glioblastoma Multiforme, Gliosarcoma | Phase 2 | Status: TERMINATED | Results posted: 2014-10-22